A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility
Articolo
Data di Pubblicazione:
2021
Citazione:
A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility / M Modlin, I; Kidd, M; Falconi, M; L Filosso, P; Frilling, A; Malczewska, A; Toumpanakis, C; Valk, G; Pacak, K; Bodei, L; E Öberg, K. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 32:11(2021), pp. 1425-1433. [10.1016/j.annonc.2021.08.1746]
Tipologia CRIS:
Articolo su rivista
Keywords:
NETest; biomarker; neuroendocrine tumor; NET; Chromogranin
Elenco autori:
M Modlin, I; Kidd, M; Falconi, M; L Filosso, P; Frilling, A; Malczewska, A; Toumpanakis, C; Valk, G; Pacak, K; Bodei, L; E Öberg, K
Link alla scheda completa:
Pubblicato in: